日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum

建立半机制群体药代动力学模型,用于预测妊娠期和产后血浆及细胞基质中富马酸替诺福韦酯和替诺福韦艾拉酚胺的暴露量

Yu, Yifan; Brooks, Kristina M; Doncel, Gustavo F; Best, Brookie M; Marzinke, Mark A; Mirochnick, Mark; Anderson, Peter; Myer, Landon; Celum, Connie; Heffron, Renee; Coleman, Jenell; Davey, Dvora Joseph; Hendrix, Craig W; Momper, Jeremiah D; Bies, Robert; Scott, Rachel K

Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s

氯法齐明在妊娠期和产后利福平耐药结核病女性患者中的药代动力学和安全性:IMPAACT P1026s 研究结果

Hughes, Jennifer A; McMorrow, Flynn; Brooks, Kristina M; Pinilla, Mauricio; Fairlie, Lee; Ngocho, James S; Stek, Alice; Best, Brookie M; Mirochnick, Mark; Wiesner, Lubbe; George, Kathleen; Knowles, Kevin; Browning, Renee; DeYampert, Tara; Hesseling, Anneke C; Decloedt, Eric; Shapiro, David E; Eke, Ahizechukwu C

Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure

妊娠期和产后比克替拉韦的群体药代动力学:依从性在维持治疗暴露中的作用

Sun, Steven; Nikanjam, Mina; Mirochnick, Mark; Powis, Kathleen M; Eke, Ahizechukwu C; Stek, Alice; Arora, Priyanka; Cressey, Tim R; Brooks, Kristina M; Best, Brookie M; Capparelli, Edmund V; Momper, Jeremiah D

Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s

妊娠期和产后使用左氧氟沙星治疗利福平耐药结核病的药代动力学和安全性:IMPAACT P1026s 研究结果

Hughes, Jennifer A; Pinilla, Mauricio; Brooks, Kristina M; Eke, Ahizechukwu C; Stek, Alice; Best, Brookie M; Mirochnick, Mark; Browning, Renee; Wiesner, Lubbe; George, Kathleen; Knowles, Kevin; De Koker, Petra; Ngocho, James S; Fairlie, Lee; Chakhtoura, Nahida; Hesseling, Anneke C; Decloedt, Eric; Shapiro, David E; van Schalkwyk, Marije

Pharmacokinetics and Safety of Bictegravir in Pregnant and Postpartum Persons With HIV and Their Infants

比克替拉韦在感染艾滋病毒的孕妇和产后妇女及其婴儿中的药代动力学和安全性

Powis, Kathleen M; Pinilla, Mauricio; McMorrow, Flynn; Stek, Alice; Brooks, Kristina M; Shapiro, David E; Knowles, Kevin; Eke, Ahizechukwu C; Greene, Elizabeth; Agwu, Allison; Topete, Lourdes; Browning, Renee; Chakhtoura, Nahida; Arora, Priyanka; Huang, Xiaoying; Best, Brookie M; Mirochnick, Mark; Momper, Jeremiah D

HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study

新生儿抗逆转录病毒治疗后HIV-1病毒库大小及评估无需抗逆转录病毒治疗即可缓解的可能性(IMPAACT P1115):一项1/2期概念验证研究

Persaud, Deborah; Bryson, Yvonne; Nelson, Bryan S; Tierney, Camlin; Cotton, Mark F; Coletti, Anne; Jao, Jennifer; Spector, Stephen A; Mirochnick, Mark; Capparelli, Edmund V; Costello, Diane; Szewczyk, Joseph; Nicodimus, Nicol; Stranix-Chibanda, Lynda; Kekitiinwa, Adeodata R; Korutaro, Violet; Reding, Christina; Carrington, Mary N; Majji, Sai; Yin, Dwight E; Jean-Philippe, Patrick; Chadwick, Ellen G

Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032

瑞德西韦在感染 COVID-19 的孕妇和非孕妇中的药代动力学和安全性:IMPAACT 2032 研究结果

Brooks, Kristina M; Baltrusaitis, Kristin; Clarke, Diana F; Nachman, Sharon; Jao, Jennifer; Purswani, Murli U; Agwu, Allison; Beneri, Christy; Deville, Jaime G; Powis, Kathleen M; Stek, Alice M; Eke, Ahizechukwu C; Shapiro, David E; Capparelli, Edmund; Greene, Elizabeth; George, Kathleen; Yin, Dwight E; Jean-Philippe, Patrick; Chakhtoura, Nahida; Bone, Frederic; Bacon, Kira; Johnston, Benjamin; Reding, Christina; Kersey, Kathryn; Humeniuk, Rita; Best, Brookie M; Mirochnick, Mark; Momper, Jeremiah D

Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age

洛匹那韦/利托那韦口服溶液在早产儿和足月儿(3个月龄前开始服用)中的安全性和药代动力学

Bekker, Adrie; Yang, Jincheng; Wang, Jiajia; Cotton, Mark F; Cababasay, Mae; Wiesner, Lubbe; Moye, Jack; Browning, Renee; Nakwa, Firdose L; Rabie, Helena; Violari, Avy; Mirochnick, Mark; Cressey, Tim R; Capparelli, Edmund V

Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study

拉米夫定用于暴露于 HIV 的早产儿的剂量:一项群体药代动力学建模和模拟研究

Bekker, Adrie; Capparelli, Edmund V; Mirochnick, Mark; Clarke, Diana F; Cotton, Mark F; Shapiro, Roger; McCarthy, Katie; Moye, Jack; Violari, Avy; Chokephaibulkit, Kulkanya; Abrams, Elaine; Penazzato, Martina; Ruel, Theodore D; Cressey, Tim R

Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s

一线抗结核药物利福平、异烟肼、乙胺丁醇和吡嗪酰胺在妊娠期和产后药代动力学和安全性:IMPAACT P1026s 研究结果

Van Schalkwyk, Marije; Bekker, Adrie; Decloedt, Eric; Wang, Jiajia; Theron, Gerhard B; Cotton, Mark F; Eke, Ahizechukwu C; Cressey, Tim R; Shapiro, David E; Bacon, Kira; Knowles, Kevin; George, Kathleen; Browning, Renee; Chakhtoura, Nahida; Rungruengthanakit, Kittipong; Wiesner, Lubbe; Capparelli, Edmund V; Stek, Alice M; Mirochnick, Mark; Best, Brookie M